Safety assessment of Lactobacillus brevis KB290 as a probiotic strain

Food and Chemical Toxicology

Volumn 47, Issue 10, 2009, Pages 2450-2453

  Yakabe, T ^a   Moore, E L ^b   Yokota, S ^c   Sui, H ^c   Nobuta, Y ^a   Fukao, M ^a   Palmer, H ^b   Yajima, N ^a  

^a KAGOME CO   (Japan)

^b Huntingdon Research Centre   (United Kingdom)

^c HATANO RESEARCH INSTITUTE   (Japan)

Author keywords

Lactic acid bacteria; Lactobacillus brevis; Probiotics; Safety

Indexed keywords

PROBIOTIC AGENT;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL CELL; BACTERIAL TRANSLOCATION; CHRONIC TOXICITY; CONTROLLED STUDY; DRUG SAFETY; FEEDING; FEMALE; GASTROINTESTINAL TRACT; GENOTOXICITY; LACTOBACILLUS BREVIS; MALE; NEUROTOXICITY; NONHUMAN; RAT; REVERTANT; TOXICITY TESTING;

ADMINISTRATION, ORAL; ANIMALS; BACTERIAL TRANSLOCATION; BLOOD CHEMICAL ANALYSIS; FEMALE; GASTROINTESTINAL TRACT; HUMANS; LACTOBACILLUS BREVIS; LONGEVITY; MALE; MUTATION; PROBIOTICS; RATS; RATS, SPRAGUE-DAWLEY; RISK ASSESSMENT; SALMONELLA TYPHIMURIUM; TOXICITY TESTS; WEIGHT GAIN;

BACTERIA (MICROORGANISMS); LACTOBACILLUS BREVIS; LONCHOCARPUS GLAUCIFOLIUS; RATTUS;

EID: 69549130589     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2009.07.001     Document Type: Article

References (42)

1. Aguirre M., and Collins M.D. Lactic acid bacteria and human clinical infection. J. Appl. Bacteriol. 75 (1993) 95-107
2. Allen, S.J., Okoko, B., Martinez, E., Gregorio, G., Dans, L.F., 2003. Probiotics for treating infectious diarrhoea. Cochrane. Database Syst. Rev. 4, CD003048.
3. Ames B.N., McCann J., and Yamasaki E. Proceedings: carcinogens are mutagens: a simple test system. Mutat. Res. 33 (1975) 27-28
4. Aznar E., Buendía B., García-Peñuela E., Escudero E., Alarcón T., and López-Brea M. Community-acquired urinary tract infection caused by vancomycin-resistant Enterococcus faecalis clinical isolate. Rev. Esp. Quimioter. 17 (2004) 263-265
5. Bai A.P., and Ouyang Q. Probiotics and inflammatory bowel diseases. Postgrad. Med. J. 82 (2006) 376-382
6. Bartlett M.S. Properties of sufficiency and statistical tests. Proc. Royal Soc. London Ser. A 160 (1937) 268-282
7. Besselink M.G., van Santvoort H.C., Buskens E., Boermeester M.A., van Goor H., Timmerman H.M., Nieuwenhuijs V.B., Bollen T.L., van Ramshorst B., Witteman B.J., Rosman C., Ploeg R.J., Brink M.A., Schaapherder A.F., Dejong C.H., Wahab P.J., van Laarhoven C.J., van der Harst E., van Eijck C.H., Cuesta M.A., Akkermans L.M., and Gooszen H.G. Dutch Acute Pancreatitis Study Group. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 371 (2008) 651-659
8. Cukovic-Cavka S., Likic R., Francetic I., Rustemovic N., Opacic M., and Vucelic B. Lactobacillus acidophilus as a cause of liver abscess in a NOD2/CARD15-positive patient with Crohn's disease. Digestion 73 (2006) 107-110
9. De Vuyst L., Schrijvers V., Paramithiotis S., Hoste B., Vancanneyt M., Swings J., Kalantzopoulos G., Tsakalidou E., and Messens W. The biodiversity of lactic acid bacteria in Greek traditional wheat sourdoughs is reflected in both composition and metabolite formation. Appl. Environ. Microbiol. 68 (2002) 6059-6069
10. Delgado S., Flórez A.B., and Mayo B. Antibiotic susceptibility of Lactobacillus and Bifidobacterium species from the human gastrointestinal tract. Curr. Microbiol. 50 (2005) 202-207
11. Drouault-Holowacz S., Bieuvelet S., Burckel A., Cazaubiel M., Dray X., and Marteau P. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome. Gastroenterol. Clin. Biol. 32 (2008) 147-152
12. D'Souza A.L., Rajkumar C., Cooke J., and Bulpitt C.J. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 324 (2002) 1361
13. Dunnett C.W. A multiple comparison procedure for comparing several treatments with a control. J. Am. Stat. Assoc. 50 (1955) 1096-1121
14. Dunnett C.W. New tables for multiple comparisons with a control. Biometrics 20 (1964) 482-491
15. Edmiston Jr. C.E., and Condon R.E. Bacterial translocation. Surg. Gynecol. Obstet. 173 (1991) 73-83
16. Ewaschuk J.B., and Dieleman L.A. Probiotics and probiotics in chronic inflammatory bowel diseases. World J. Gastroenterol. 12 (2006) 5941-5950
17. FAO/WHO, 2001. Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. ftp://ftp.fao.org/es/esn/food/probio_report_en.pdf.
18. Fisher, R.A., 1973. In: Statistical Methods for Research Workers, 14th ed. Hafner Publishing Company, New York, p. 96.
19. Gu R.X., Yang Z.Q., Li Z.H., Chen S.L., and Luo Z.L. Probiotic properties of lactic acid bacteria isolated from stool samples of longevous people in regions of Hotan, Xinjiang and Bama, Guangxi, China. Anaerobe 14 (2008) 313-317
20. Ha G.Y., Yang C.H., Kim H., and Chong Y. Case of sepsis caused by Bifidobacterium longum. J. Clin. Microbiol. 37 (1999) 1227-1228
21. Hamilton-Miller J.M. Probiotics and prebiotics in the elderly. Postgrad. Med. J. 80 (2004) 447-451
22. Kishi A., Uno K., Matsubara Y., Okuda C., and Kishida T. Effect of the oral administration of Lactobacillus brevis subsp. coagulans on interferon-alpha producing capacity in humans. J. Am. Coll. Nutr. 15 (1996) 408-412
23. Mach T. Clinical usefulness of probiotics in inflammatory bowel diseases. J. Physiol. Pharmacol. 57 (2006) 23-33
24. Mante E.S., Sakyi-Dawson E., and Amoa-Awua W.K. Antimicrobial interactions of microbial species involved in the fermentation of cassava dough into agbelima with particular reference to the inhibitory effect of lactic acid bacteria on enteric pathogens. Int. J. Food Microbiol. 89 (2003) 41-50
25. McFarland L.V., and Dublin S. Meta-analysis of probiotics for the treatment of irritable bowel syndrome. World J. Gastroenterol. 14 (2008) 2650-2661
26. Nobuta, Y., Inoue, T., Suzuki, S., Arakawa, C., Yakabe, T., Ogawa, M., Yajima, N., 2009. The efficacy and the safety of Lactobacillus brevis KB290 as a human probiotics. Int. J. Probiotics Prebiotics, in press.
27. Ohta T., Watanabe-Akanuma M., Tokishita S., Shiga Y., and Yamagata H. Development of new tester strains derived from E. coli WP2 uvrA for the determination of mutational specificity. Mutat. Res. 30 (1998) 219-225
28. Ouwehand A.C. Antiallergic effects of probiotics. J. Nutr. 137 (2007) 794S-797S
29. Ouwehand A.C., Tuomola E.M., Tölkkö S., and Salminen S. Assessment of adhesion properties of novel probiotic strains to human intestinal mucus. Int. J. Food Microbiol. 64 (2001) 119-126
30. Pham M., Lemberg D.A., and Day A.S. Probiotics: sorting the evidence from the myths. Med. J. Aust. 188 (2008) 304-308
31. Presterl E., Kneifel W., Mayer H.K., Zehetgruber M., Makristathis A., and Graninger W. Endocarditis by Lactobacillus rhamnosus due to yogurt ingestion?. Scand. J. Infect. Dis. 33 (2001) 710-714
32. Rautio M., Jousimies-Somer H., Kauma H., Pietarinen I., Saxelin M., Tynkkynen S., and Koskela M. Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clin. Infect. Dis. 28 (1999) 1159-1160
33. Rönkä E., Malinen E., Saarela M., Rinta-Koski M., Aarnikunnas J., and Palva A. Probiotic and milk technological properties of Lactobacillus brevis. Int. J. Food Microbiol. 83 (2003) 63-74
34. Salminen M.K., Rautelin H., Tynkkynen S., Poussa T., Saxelin M., Valtonen V., and Järvinen A. Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin. Infect. Dis. 38 (2004) 62-69
35. Sánchez I., Palop L., and Ballesteros C. Biochemical characterization of lactic acid bacteria isolated from spontaneous fermentation of 'Almagro' eggplants. Int. J. Food Microbiol. 59 (2000) 9-17
36. Shirley E.A.C. A non-parametric equivalent of Williams' test for contrasting increasing dose levels of a treatment. Biometrics 33 (1977) 386-389
37. Soo I., Madsen K.L., Tejpar Q., Sydora B.C., Sherbaniuk R., Cinque B., Di Marzio L., Cifone M.G., Desimone C., and Fedorak R.N. VSL#3 probiotic upregulates intestinal mucosal alkaline sphingomyelinase and reduces inflammation. Can. J. Gastroenterol. 22 (2008) 237-242
38. Steel R.G.D. A multiple comparison rank sum test: treatments versus control. Biometrics 15 (1959) 560-572
39. Wallet F., Dessein R., Armand S., and Courcol R.J. Molecular diagnosis of endocarditis due to Lactobacillus casei subsp. rhamnosus. Clin. Infect. Dis. 35 (2002) e117-119
40. Williams D.A. A test for differences between treatment means when several dose levels are compared with a zero dose control. Biometrics 27 (1971) 103-117
41. Williams D.A. The comparison of several dose levels with a zero dose control. Biometrics 28 (1972) 519-531
42. Zé-Zé L., Tenreiro R., Duarte A., Salgado M.J., Melo-Cristino J., Lito L., Carmo M.M., Felisberto S., and Carmo G. Case of aortic endocarditis caused by Lactobacillus casei. J. Med. Microbiol. 53 (2004) 451-453